| Literature DB >> 33194991 |
Jifeng Liu1,2, Tengfei Ma1,2, Mingzhong Gao3, Yilin Liu4, Jun Liu1, Shichao Wang2, Yike Xie2, Qiao Wen1, Ling Wang2, Juan Cheng2, Shixi Liu1, Jian Zou1,2, Jiang Wu2, Weimin Li2, Heping Xie2,3,5.
Abstract
Background: There has been a considerable concern about cancer induction in response to radiation exposure. However, only a limited number of studies have focused on the biological effects of below-background radiation (BBR) in deep underground environments. To improve our understanding of the effects of BBR on cancer, we studied its biological impact on well-differentiated laryngeal squamous cell carcinoma cells (FD-LSC-1) in a deep underground laboratory (DUGL).Entities:
Keywords: FD-LSC-1 cell; below background radiation; cell proliferation; deep-underground; proteomics; ribosome; stress
Mesh:
Year: 2020 PMID: 33194991 PMCID: PMC7661695 DOI: 10.3389/fpubh.2020.584964
Source DB: PubMed Journal: Front Public Health ISSN: 2296-2565
Figure 1Flow chart of the study design. AGL, above-ground laboratory; DUGL, deep underground laboratory.
Figure 2FD-LSC-1 cells cultured for 4 days in the DUGL or AGL observed using light microscopy (at 10 × magnification). AGL, above-ground laboratory; DUGL, deep underground laboratory. The cell density in the DUGL group was observably lower than that in the AGL group on the corresponding day.
Figure 3(A) PRM verification results of the selected DAPs (AGL/DUGL); (B) Growth curves of FD-LSC-1 cells cultured in the DUGL or AGL; (C) Volcano plot (red, upregulated DAPs; black, unchanged DAPs; green, downregulated DAPs [AGL/DUGL]). DAPs, differentially abundant proteins; DUGL, deep underground laboratory; AGL, above-ground laboratory; PRM, parallel reaction monitoring.
Figure 4Transmission electron microscopy images of FD-LSC-1 cells cultured in the AGL (A) and DUGL (B) (at 2,500 × magnification). White arrows, endoplasmic reticulum; M, mitochondria; AGL, above-ground laboratory; DUGL, deep underground laboratory.
Figure 5GO and KEGG enrichment analysis of the total DAPs. (A) GO analysis result; (B) KEGG pathway analysis result. DAPs, differentially abundant proteins.
Figure 6GO and KEGG enrichment analysis of the upregulated and downregulated DAPs. (A) Results of GO analysis of upregulated DAPs in cells from the DUGL group; (B) Results of GO analysis of downregulated DAPs in cells from the DUGL group. DAPs, differentially abundant proteins.
KEGG pathway enrichment result.
| Ribosome | 17 | RPL39, RPS28, RPL30, RPL37A, RPL22, RPL38, RPL35A, RPS12, RPL34, RPS25, RPS27, RPL36, RPL26, MRPS17, RPS26, RPLP2, RPL36A | 3 | RPL7, RPS2, RPL4 | |
| Spliceosome | 0.0001 | 13 | SF3A2, SNRPF, DDX46, SLU7, ZMAT2, TRA2A, SMNDC1, LSM6, LSM5, SRSF3, SRSF5, SNRPD2, LSM2 | 5 | HSPA8, PRPF40A, ISY1, PCBP1, HNRNPA1 |
| Oxidative phosphorylation | 0.00043 | 14 | COX6C, UQCR10, ATP5ME, NDUFB3, NDUFAB1, NDUFS5, UQCRH, NDUFB1, ATP5PF, ATP5F1E, COX4I1, NDUFA2, COX6B1, ATP6V1G1 | 0 | |
| Protein export | 0.00086 | 2 | SEC61B, SRP19 | 4 | SRPRA, SRPRB, HSPA5, SRP72 |
| Thermogenesis | 0.00086 | 17 | COX6C, UQCR10, COX19, COA7, ATP5ME, KDM3B, SMARCD2, NDUFB3, COX20, NDUFAB1, NDUFS5, UQCRH, NDUFB1, ATP5PF, ATP5F1E, NDUFA2, COX6B1 | 1 | PRKACA |
| Protein processing in endoplasmic reticulum | 0.00108 | 3 | RBX1, SEC61B, WFS | 10 | EDEM3, HSPA8, ERP29, DNAJA1, P4HB, CANX, HSPA5, STT3B, HSP90AA1, HSP90AB1 |
| Non-alcoholic fatty liver disease | 0.0421 | 11 | COX6C, UQCR, NDUFB, NDUFAB1, BID, NDUFS5, UQCRH, NDUFB1, COX4I1, NDUFA, COX6B1 | 0 |
Results of DAP verification by parallel reaction monitoring.
| ITIH3 | 0.4017319 | 2.844 | |
| SERPINF2 | 0.3238109 | 0.512 | |
| PTTG1IP | 0.665582 | 0.86 | |
| HMGB3 | 0.6464124 | 0.944 | |
| F2 | 0.6469235 | 0.383 | |
| SLC43A3 | 1.519244 | 1.302 | |
| APOA1 | 0.3153911 | 0.227 | |
| CHMP6 | 0.6435466 | 1.76 | |
| CYR61 | 0.4987531 | 0.427 | |
| A2M | 0.411034 | 0.514 | |
| C3 | 0.390117 | 0.282 | |
| COL3A1 | 0.4081448 | 0.378 | |
| SERPINA7 | 0.3045479 | 0.259 | |
| COX6C | 0.6596789 | 0.87 | |
| ALPI | 1.57784 | 1.171 | |
| KRT10 | 0.4975399 | 1.243 | |
| KRT5 | 0.6197494 | 0.174 | |
| FDPS | 1.619579 | 1.568 | |
| HMGA1 | 0.6389323 | 0.714 | |
| KRT9 | 0.4700966 | 0.457 | |
| KRT2 | 0.5715737 | 0.253 | |
| AFM | 0.2987056 | 0.418 | |
| S100A10 | 0.5489479 | 0.246 | |
| B2M | 0.633045 | 0.113 | |
| DCD | 0.6339814 | 0.917 | |
| RBM3 | 0.4456107 | 0.694 | |
| FABP5 | 0.6432707 | 1.304 | |
| SF3A2 | 0.6603566 | 1.41 | |
| TBC1D10B | 0.4632966 | 1.747 | |
| ITIH2 | 0.3368894 | 0.393 | |
| NCCRP1 | 1.517451 | 2.281 | |
| SREK1 | 0.5544262 | 1.554 | |
| C18orf25 | 0.6465517 | 0.837 | |
| GON7 | 0.6654836 | 0.607 | |
| DICER1 | 0.574236 | 1.017 |
Figure 7PPI network of DAPs in FD-LSC-1 cells. Coloration with gradient: from yellow (lower p-value) to blue (higher p-value). The proteins with different abundances are indicated in red (upregulation in the AGL group) and green (downregulation in the AGL group). The default confidence cutoff value was fixed at 400. The red solid lines represent activation. The blue dashed lines indicate the KEGG pathway. PPI, protein-protein interaction; DAPs, differentially abundant proteins.